Work

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.3592

Authors: Benny Johnson, Dong Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari, Kanwal Pratap Singh Raghav, Bryan K. Kee, John Paul Y.C. Shen, Ryan Huey, Michael Sangmin Lee, Christine Megerdichian Parseghian, Phat Le, Maria Pia Morelli, Jason Willis, Robert A. Wolff, Leylah Drusbosky, Michael J. Overman, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, Guardant (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4282026401

Cites:

Cited by:

Related to: 10